.svg){kind=icon}
Patient Engagement in Clinical Research
Bring trials directly to patients to improve access and engagement, increase quality and shorten timelines.
Publication
IQVIA ranked #1 in Everest Group's Top 50™ Pharmaceutical Technology Providers 2026
Feb 04, 2025
Explore the 2024 IDC MarketScape excerpt to gain insights into IQVIA's flexible DCT approaches for life sciences companies. This comprehensive report highlights the exceptional strengths of our portfolio, featuring purpose-built DCT technologies such as eCOA, eConsent, Study Hub, telemedicine, connected devices, and services like labs and home health nursing.
Our integrated strategy enables customers to adopt, run, and execute decentralized trial approaches, delivering a unique and differentiating experience.
Related solutions
Orchestrated Clinical Trials
Ease the burden on your sites and make it easier and more appealing for patients to enroll and remain engaged.
Clinical Research & Development Solutions
Explore our end-to-end, full service clinical development capabilities including Therapeutics expertise, Development Planning, Phase I early clinical development, Phase IIb/III and Phase IV Trials, Regulatory Submission and Post-Launch Studies.